Tag: Eculizumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Eculizumab

FDA clears Amgen's Bkemv as first biosimilar of Soliris - Pharmaphorum

Added to Collection on: 2024-05-29 21:48:08

Tags for this article:

Orphan drugs
Monoclonal antibodies
Acquired hemolytic anemia
Immunosuppressants
Eculizumab
Hemolytic–uremic syndrome
Paroxysmal nocturnal hemoglobinuria
Ravulizumab
Amgen
Alexion Pharmaceuticals
United States
Soliris

Click the tags to see associated articles and topics

View Article Details
Two novel biosimilars approved in EU and US - European Pharmaceutical Review

Added to Collection on: 2024-05-29 16:41:40

Tags for this article:

Monoclonal antibodies
Acquired hemolytic anemia
Orphan drugs
Immunosuppressants
Eculizumab
Omalizumab
Alexion Pharmaceuticals
Paroxysmal nocturnal hemoglobinuria
Celltrion
Hemolytic–uremic syndrome
Thrombotic microangiopathy
Hemolysis

Click the tags to see associated articles and topics

View Article Details
AstraZeneca Loses Bid to Block Soliris Biosimilar During Appeal - Bloomberg Law News

Added to Collection on: 2024-06-18 16:30:25

Tags for this article:

Specialty drugs
Immunosuppressants
Monoclonal antibodies
Orphan drugs
Samsung
Samsung Biologics
Eculizumab
Alexion Pharmaceuticals
AstraZeneca
Biosimilar
Biopharmaceutical
Pharmaceutical industry in India
AstraZeneca plc
Alexion Pharmaceuticals Inc.
Samsung BioLogics Co

Click the tags to see associated articles and topics

View Article Details
Voydeya approved in Canada as add-on therapy to ravulizumab or eculizumab for adults ... - Placera

Added to Collection on: 2024-07-23 17:05:58

Tags for this article:

Orphan drugs
Immunosuppressants
Monoclonal antibodies
Hematology
Rare diseases
Eculizumab
Paroxysmal nocturnal hemoglobinuria
Ravulizumab
Alexion Pharmaceuticals
Danicopan
Hemolytic anemia
Hemolysis
Soliris

Click the tags to see associated articles and topics

View Article Details
Atypical Hemolytic Uremic Syndrome Treatment Market 2034: - openPR.com

Added to Collection on: 2024-08-26 15:17:01

Tags for this article:

Blood disorders
Monoclonal antibodies
Acquired hemolytic anemia
Nephrology
Ahus
Complement system
Atypical hemolytic uremic syndrome
Alexion Pharmaceuticals
Hemolytic–uremic syndrome
Hemolysis
Complement factor I
Eculizumab

Click the tags to see associated articles and topics

View Article Details
NICE recommendation for new Alexion PNH treatment - PharmaTimes

Added to Collection on: 2024-10-24 15:34:41

Tags for this article:

Orphan drugs
Monoclonal antibodies
Immunosuppressants
Rare diseases
Complement system
Ravulizumab
Paroxysmal nocturnal hemoglobinuria
Eculizumab
Hemolysis
Hemolytic anemia
Factor D
AstraZeneca
Alexion

Click the tags to see associated articles and topics

View Article Details
CDSCO approves AstraZeneca's anti-complement medicine Eculizumab - Express Pharma

Added to Collection on: 2025-01-17 16:04:40

Tags for this article:

Acquired hemolytic anemia
Blood disorders
Rare diseases
Hematology
Atypical hemolytic uremic syndrome
Syndromes
Hemolytic–uremic syndrome
Hemolysis
Eculizumab
Thrombotic microangiopathy
Paroxysmal nocturnal hemoglobinuria
Ahus
ASTRAZENECA PHARMA INDIA

Click the tags to see associated articles and topics

View Article Details
UPC Court of Appeal confirms strict approach to correcting patent errors by interpretation

Added to Collection on: 2025-02-04 18:53:51

Tags for this article:

European Patent Organisation
Patent law
European Patent Convention
Prior art
United States patent law
Eculizumab
Person having ordinary skill in the art
Patent claim
Amendments under the European Patent Convention
Kirin-Amgen Inc v Hoechst Marion Roussel Ltd

Click the tags to see associated articles and topics

View Article Details
Delaware Supreme Court reverses trial court for failing to apply "Interrelated Wrongful Acts ...

Added to Collection on: 2025-02-07 16:14:27

Tags for this article:

Types of insurance
Specialty drugs
Alexion Pharmaceuticals
AstraZeneca
Directors and officers liability insurance
Securities Act
Eculizumab
Class action
Securities Class Action
Liability insurance
SEC Rule 10b-5
United States Securities Regulation

Click the tags to see associated articles and topics

View Article Details
Atypical Hemolytic Uremic Syndrome Market Expected to rise, - openPR.com

Added to Collection on: 2025-02-06 20:07:40

Tags for this article:

Blood disorders
Rare diseases
Acquired hemolytic anemia
Monoclonal antibodies
Kidney diseases
Atypical hemolytic uremic syndrome
Ahus
Hemolytic–uremic syndrome
Alexion Pharmaceuticals
Hemolysis
Eculizumab
Complement factor I
United States

Click the tags to see associated articles and topics

View Article Details